These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. G protein-coupled receptors as therapeutic targets for obesity and type 2 diabetes. Bjenning C; Al-Shamma H; Thomsen W; Leonard J; Behan D Curr Opin Investig Drugs; 2004 Oct; 5(10):1051-62. PubMed ID: 15535426 [TBL] [Abstract][Full Text] [Related]
11. Sleep hormones. Preface. Litwack G Vitam Horm; 2012; 89():xvii-xviii. PubMed ID: 22640623 [No Abstract] [Full Text] [Related]
12. Preface. Slesinger PA; Wickman K Int Rev Neurobiol; 2015; 123():xi-xii. PubMed ID: 26422989 [No Abstract] [Full Text] [Related]
13. From fish tail to human brain. Preface. Bern HA Peptides; 2008 May; 29(5):649-50. PubMed ID: 17942193 [No Abstract] [Full Text] [Related]
14. Pharmacology and therapeutics of constitutively active receptors. Preface. Tao YX Adv Pharmacol; 2014; 70():ix-x. PubMed ID: 24931204 [No Abstract] [Full Text] [Related]
15. [Expression of orexin receptor 1 in rat pancreatic tissue with alimentary obesity]. Tian L; Zhao YY; Wang L; Ma DJ Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):409-11. PubMed ID: 21418915 [TBL] [Abstract][Full Text] [Related]
17. Growth hormone secretagogue receptor antagonists as anti-obesity therapies? Still an open question. Zhao H; Liu G Curr Opin Drug Discov Devel; 2006 Jul; 9(4):509-15. PubMed ID: 16889233 [TBL] [Abstract][Full Text] [Related]